Company profile · free preview
ANI Pharmaceuticals
ANIP · Updated 10/24/2026
Revenue
$883.4M
Fiscal 2025
Net income
$78.3M
Fiscal 2025
Free cash flow
$171.4M
Fiscal 2025
Net cash / (debt)
—
Fiscal 2025
Five-year financials
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $883.4M | $614.4M | $486.8M | $316.4M | $216.1M |
| Net income | $78.3M | (18.5M) | $18.8M | (47.9M) | (42.6M) |
| Diluted EPS | — | — | — | — | — |
| Operating cash flow | $185.2M | $64.0M | $119.0M | (31.2M) | $3.3M |
| Free cash flow | $171.4M | $47.8M | $110.1M | (40.1M) | $765000 |
| Cash | $285.6M | $144.9M | $221.1M | $48.2M | $100.3M |
| Total debt | — | — | — | — | — |
Where the cash went
Cumulative, fiscal 2021–2025, straight from the reported cash-flow statements.
Reinvested in capex
14.8%
of operating cash flow
Returned to owners
—
of free cash flow (buybacks + dividends)
Diluted share count
—
change 2021–2025
Capital expenditure $50.4MBar width = share of $340.3M operating cash flow
| Operating cash flow | $340.3M |
| Capital expenditure | ($50.4M) |
| Free cash flow | $289.9M |
| Share buybacks | — |
| Dividends paid | — |
| Acquisitions (net) | — |
| Net debt issued / (repaid) | — |
| Stock-based compensation (non-cash) | — |
"—" means a year didn't report that line, so no total is shown rather than an estimate.
SEC filings
No filings stored yet.
Ask anything about ANI Pharmaceuticals's filings
"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.
Start researching freeMore companies
Dream Finders Homes DFHNetflix, Inc. NFLXBHP Group BHPDell Technologies Inc. DELLAdobe Inc. ADBEXOM XOMChipotle Mexican Grill, Inc. CMGALM ALMLKQ LKQSE SECoreWeave, Inc. Class A Common Stock CRWVMeta Platforms, Inc. METARobinhood Markets, Inc. HOODCredo Technologies CRDOMSTR MSTRMaxLinear, Inc. MXLApple Inc. AAPLNBIS NBISLLY LLYBaker Hughes Company BKRSalesforce, Inc. CRMConocoPhillips COPPalo Alto Networks, Inc. PANWCSQR CSQR